NCT00050440 Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma Status COMPLETED Phase PHASE2
NCT00050414 A Study of Trabectedin in Patients With Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00049374 Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00041132 S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00040937 S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00039130 Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia Status COMPLETED Phase PHASE2
NCT00038610 Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00033332 Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00030069 Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes Status COMPLETED Phase PHASE2
NCT00028886 Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma Status UNKNOWN Phase PHASE3
NCT00026234 Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver Status COMPLETED Phase PHASE2
NCT00025636 Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma Status UNKNOWN Phase PHASE3
NCT00025259 Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Status COMPLETED Phase PHASE3
NCT00024167 Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Status TERMINATED Phase PHASE3
NCT00022737 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00022126 Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00021359 Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00017602 Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3